William Abbey - Arm Holdings Executive Officer
| ARM Stock | 135.99 2.85 2.14% |
Executive
William Abbey is Executive Officer of Arm Holdings plc
| Age | 53 |
| Address | 110 Fulbourn Road, Cambridge, United Kingdom, CB1 9NJ |
| Phone | 44 1223 400 400 |
| Web | https://www.arm.com |
Arm Holdings Management Efficiency
The company has Return on Asset of 0.0308 % which means that on every $100 spent on assets, it made $0.0308 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1189 %, implying that it generated $0.1189 on every 100 dollars invested. Arm Holdings' management efficiency ratios could be used to measure how well Arm Holdings manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Arm Holdings' Return On Tangible Assets are very stable compared to the past year. As of the 23rd of November 2024, Return On Assets is likely to grow to 0.07, while Return On Capital Employed is likely to drop 0.02. At this time, Arm Holdings' Non Current Assets Total are very stable compared to the past year. As of the 23rd of November 2024, Return On Tangible Assets is likely to grow to 0.1, while Net Tangible Assets are likely to drop about 2.2 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Benford Mokoatle | Gold Fields Ltd | 50 | |
| Mark Underwood | Madrigal Pharmaceuticals | N/A | |
| Betty Larson | Merck Company | 48 | |
| Thomas Hare | Madrigal Pharmaceuticals | N/A | |
| Jennifer JD | Merck Company | 46 | |
| Peter Dannenbaum | Merck Company | N/A | |
| Jacob Ricciardone | Gold Fields Ltd | N/A | |
| Brian JD | Madrigal Pharmaceuticals | 62 | |
| Dalton III | Merck Company | 57 | |
| Ronald Filippo | Madrigal Pharmaceuticals | N/A | |
| Edward Chiang | Madrigal Pharmaceuticals | N/A | |
| Naseem BE | Gold Fields Ltd | 63 | |
| Joerg Koglin | Merck Company | N/A | |
| Jongisa Magagula | Gold Fields Ltd | 42 | |
| Gideon Blumenthal | Merck Company | N/A | |
| Max Combes | Gold Fields Ltd | N/A | |
| Clint Wallace | Madrigal Pharmaceuticals | N/A | |
| Shannon Kelley | Madrigal Pharmaceuticals | N/A | |
| Paul Lancaster | Amtech Systems | N/A | |
| Jacques Rensburg | Gold Fields Ltd | N/A | |
| MSc MS | Gold Fields Ltd | 63 | |
Management Performance
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0308 |
Arm Holdings plc Leadership Team
Elected by the shareholders, the Arm Holdings' board of directors comprises two types of representatives: Arm Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Arm. The board's role is to monitor Arm Holdings' management team and ensure that shareholders' interests are well served. Arm Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Arm Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tamika Smith, Senior Officer | ||
| Spencer Collins, Executive Officer | ||
| Drew Henry, Executive Ecosystem | ||
| Charlotte Eaton, Chief Officer | ||
| Laura Bartels, Chief Officer | ||
| William Abbey, Executive Officer | ||
| Ami Badani, Chief Officer | ||
| Kirsty Gill, Executive Officer | ||
| Ian Thornton, Head Relations | ||
| Jason Child, Executive CFO | ||
| Richard Grisenthwaite, Executive Architect | ||
| Rene Haas, CEO Director |
Arm Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Arm Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0308 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 137.84 B | ||||
| Shares Outstanding | 1.05 B | ||||
| Shares Owned By Insiders | 87.80 % | ||||
| Shares Owned By Institutions | 6.35 % | ||||
| Number Of Shares Shorted | 14.47 M | ||||
| Price To Book | 23.28 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arm Holdings plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Semiconductors & Semiconductor Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arm Holdings. If investors know Arm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arm Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.1 | Earnings Share 0.6 | Revenue Per Share 3.404 | Quarterly Revenue Growth 0.047 | Return On Assets 0.0308 |
The market value of Arm Holdings plc is measured differently than its book value, which is the value of Arm that is recorded on the company's balance sheet. Investors also form their own opinion of Arm Holdings' value that differs from its market value or its book value, called intrinsic value, which is Arm Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arm Holdings' market value can be influenced by many factors that don't directly affect Arm Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arm Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arm Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arm Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.